Deregulated epidermal growth factor receptor (EGFR) signaling is a key feature in different stages of oncogenesis. One important mechanism whereby cancer cells achieve increased and uncontrolled EGFR signaling is escaping down-modulation of the receptor. Ubiquitylation of the EGFR plays a decisive role in this process, as it regulates receptor internalization, trafficking and degradation. Deubiquitinating enzymes (DUBs) may oppose the ubiquitylation process, antagonizing or even promoting receptor degradation. Here, we use qualitative and quantitative assays to measure EGFR internalization and degradation after Ubiquitin Specific Peptidase 25 (USP25) depletion. We show that, by acting at the early steps of EGFR internalization, USP25 restrains the degradation of the EGFR by assisting in the association of the E3 ubiquitin ligase c-Cbl with EGFR, thereby modulating the amplitude of ubiquitylation on the receptor. This study establishes USP25 as a negative regulator of the EGFR down-modulation process and suggests that it is a promising target for pharmacological intervention to hamper oncogenic growth signals in tumors that depend on the EGFR.
USP25 regulates EGFR fate by modulating EGF-induced ubiquitylation dynamics / C.A. Nino, N. Wollscheid, G. Giangreco, E. Maspero, S. Polo. - In: BIOMOLECULES. - ISSN 2218-273X. - 10:11(2020 Nov), pp. 1548.1-1548.16.
|Titolo:||USP25 regulates EGFR fate by modulating EGF-induced ubiquitylation dynamics|
POLO, SIMONA LAURA ANNA (Corresponding)
|Parole Chiave:||Cancer; Deubiquitylating enzymes; EGFR; Ubiquitin; Ubiquitylation|
|Settore Scientifico Disciplinare:||Settore MED/04 - Patologia Generale|
|Data di pubblicazione:||nov-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.3390/biom10111548|
|Appare nelle tipologie:||01 - Articolo su periodico|